New Clinical Studies Reinforce the LAP-BANDÃ‚® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions
IRVINE, Calif., April 13, 2011 /PRNewswire/ -- Two new studies published in the current issue of Surgery for Obesity and Related Diseases, a peer-reviewed journal, add to the large body of scientific evidence which supports that the LAP-BAND® Adjustable Gastric Banding System, made by Allergan, Inc. (NYSE: AGN), is a safe and effective weight-loss procedure. One study concluded that laparoscopic adjustable gastric banding (LAGB) procedure can be safely performed in a community medical practice, with patients experiencing meaningful excess weight loss. The second study examined patients who received LAGB following the failure of gastric bypass and found they achieved significant weight loss two years post-banding procedure.
While a wealth of data has been published in the literature worldwide, questions have recently been raised about the safety and effectiveness of the LAP-BAND® System, specifically with respect to average weight loss and complications. These two new studies support that the advanced product technology of the LAP-BAND® AP System, combined with surgical technique and patient aftercare result in positive clinical outcomes. The LAP-BAND® System has an 18-year safety and effectiveness record, including almost 10-years in the United States, with more than 650,000 procedures performed worldwide, leading to more than two million patient years of exposure for the device.
Key Study Findings Published in Surgery for Obesity and Related Diseases:
The first study, by James B. Ray, M.D., F.A.C.S. and Shahla Ray, Ph.D., of the Center for Advanced Laparoscopic and Bariatric Surgery, Bloomington, IN, followed one surgeon's practice for five years (March 30, 2004 to December 2, 2009) in which 442 LAGB procedures were performed. The study found that on average patients achieved 48 percent excess we